Loading clinical trials...
Loading clinical trials...
The purpose of the study was to assess the steady-state pharmacokinetics (PK) of efavirenz (EFV) in human immunodeficiency virus type 1 (HIV-1) infected subjects on stable antiretroviral regimens cont...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Bristol-Myers Squibb
NCT07269301 · Hepatic Impairment, Healthy
NCT07457229 · Hepatic Impairment
NCT06694805 · HIV Infections
NCT06627764 · Substance Abuse, Intimate Partner Violence (IPV), and more
NCT04142047 · HIV, HIV Infections
Johns Hopkins University School Of Medicine
Baltimore, Maryland
Uthscsa
San Antonio, Texas
Virginia Commonwealth University Health Systems
Richmond, Virginia
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions